Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: Dependence on phenotype, severity and therapy

British Journal of Dermatology

Volumn 156, Issue 5, 2007, Pages 875-883

  Komatsu, N ^a,b,c   Saijoh, K ^c   Kuk, C ^a   Shirasaki, F ^c   Takehara, K ^c   Diamandis, E P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Diagnostic marker; Human kallikreins; Psoriasis; Serine proteases; Stratum corneum; Therapy

Indexed keywords

CHYMOTRYPSIN; COLECALCIFEROL; CORTICOSTEROID; CYCLOSPORIN A; ETRETINATE; FURIN; KALLIKREIN; NEUROPSIN; PLASMIN; PSORALEN; SERINE PROTEINASE; TRYPSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; PUVA; STRATUM CORNEUM;

ADULT; AGED; CASE-CONTROL STUDIES; CHYMASES; ETRETINATE; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PHENOTYPE; PSORIASIS; SKIN; TISSUE KALLIKREINS;

EID: 34247350818     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07743.x     Document Type: Article

References (47)

1. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 2005 5:699 711.
2. Gottlieb AB. Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov 2005 4:19 34.
3. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev 2001 22:184 204.
4. Komatsu N, Saijoh K, Sidiropoulos M et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J Invest Dermatol 2005 125:1182 92.
5. Komatsu N, Tsai B, Sidiropoulos M et al. Quantification of eight tissue kallikreins in the stratum corneum and sweat. J Invest Dermatol 2006 126:925 9.
6. Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process? J Invest Dermatol 2000 114:56 63.
7. Komatsu N, Saijoh K, Toyama T et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol 2005 153:274 81.
8. Ishida-Yamamoto A, Simon M, Kishibe M et al. Epidermal lamellar granules transport different cargoes as distinct aggregates. J Invest Dermatol 2004 122:1137 44.
9. Ishida-Yamamoto A, Deraison C, Bonnart C et al. LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum. J Invest Dermatol 2005 124:360 6.
10. Simon M, Jonca N, Guerrin M et al. Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 2001 276:20292 9.
11. Caubet C, Jonca N, Brattsand M et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004 122:1235 44.
12. Yousef GM, Diamandis EP. Human tissue kallikreins: a new enzymatic cascade pathway? Biol Chem 2002 383:1045 57.
13. Brattsand M, Stefansson K, Lundh C et al. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005 124:198 203.
14. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004 84:579 621.
15. Steinhoff M, Corvera CU, Thoma MS et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 1999 8:282 94.
16. Oikonomopoulou K, Hansen KK, Saifeddine M et al. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more. Biol Chem 2006 387:677 85.
17. Oikonomopoulou K, Hansen KK, Saifeddine M et al. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol Chem 2006 387:817 24.
18. Christophi GP, Isackson PJ, Blaber S et al. Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease. J Neurochem 2004 9:1439 49.
19. Blaber SL, Ciric B, Christophi GP et al. Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J 2004 18:920 2.
20. Gan L, Lee I, Smith R et al. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 2000 257:119 30.
21. Ekholm E, Egelrud T. Stratum corneum chymotryptic enzyme in psoriasis. Arch Dermatol Res 1999 291:195 200.
22. Suzuki Y, Koyama J, Moro O et al. The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 1996 134:460 4.
23. Magert HJ, Standker L, Kreutzmann P et al. LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem 1999 274:21499 502.
24. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000 25:141 2.
25. Mitsudo K, Jayakumar A, Henderson Y et al. Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis. Biochemistry 2003 42:3874 81.
26. Descargues P, Deraison C, Bonnart C et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005 37:56 65.
27. Egelrud T, Brattsand M, Kreutzmann P et al. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J Dermatol 2005 153:1200 3.
28. Schechter NM, Choi EJ, Wang ZM et al. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI). Biol Chem 2005 386:1173 84.
29. Seidah NG, Chretien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 1999 848:45 62.
30. Komatsu N, Takata M, Otsuki N et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 2002 118:436 43.
31. Bitoun E, Micheloni A, Lamant L et al. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution, and defective expression in Netherton syndrome. Hum Mol Genet 2003 12:2417 30.
32. Franzke CW, Baici A, Bartels J et al. Antileukoprotease inhibits stratum corneum chymotryptic enzyme. Evidence for a regulative function in desquamation. J Biol Chem 1996 271:21886 90.
33. Michael IP, Sotiropoulou G, Pampalakis G et al. Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression. J Biol Chem 2005 280:14628 35.
34. Magklara A, Mellati AA, Wasney GA et al. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors. Biochem Biophys Res Commun 2003 307:948 55.
35. Oka T, Hakoshima T, Itakura M et al. Role of loop structures of neuropsin in the activity of serine protease and regulated secretion. J Biol Chem 2002 277:14724 30.
36. Kapadia C, Yousef GM, Mellati AA et al. Complex formation between human kallikrein 13 and serum protease inhibitors. Clin Chim Acta 2004 339:157 67.
37. Felber LM, Borgono CA, Cloutier SM et al. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biol Chem 2005 386:291 8.
38. Komatsu N, Saijoh K, Otsuki N et al. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein. Clin Chim Acta 2007 377:228 36.
39. Borgono CA, Michael IP, Komatsu N et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007 in press.
40. Iwakiri K, Ghazizadeh M, Jin E et al. Human airway trypsin-like protease induces PAR-2-mediated IL-8 release in psoriasis vulgaris. J Invest Dermatol 2002 122:937 44.
41. Rampart M, van Damme J, Zonnekeyn L et al. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989 135:21 5.
42. Gillitzer R, Ritter U, Spandau U et al. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996 107:778 82.
43. Biasi D, Carletto A, Caramaschi P et al. Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation 1998 22:533 43.
44. Zollner TM, Podda M, Pien C et al. Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest 2002 109:671 9.
45. Moreau ME, Garbacki N, Molinaro G et al. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005 99:6 38.
46. Chao J, Bledsoe G, Yin H et al. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol Chem 2006 387:665 75.
47. Emanueli C, Minasi A, Zacheo A et al. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 2001 103:125 32.